You are Mateo Bohórquez-Lozada, 49, eleven weeks into your new role as CEO of Saludía Andina, a Bogotá-based mid-cap consumer-health firm. The strategy you sold to the board was clear. The org chart you inherited is not.
The situation
Saludía Andina sells vitamins, probiotics, women's-health and dermocosmetic products under five brands. COP 480bn revenue, 1,640 employees, 14 years old, controlled by Andean PE house Cordillera Capital (62%) with a 24-month exit window. Historically organized as five functional silos — Operations, Commercial, Marketing, R&D, Finance — reporting straight to the CEO. The model worked at 800-person scale; at 1,640 it groans.
Your strategy, approved in the March board, has three pillars: (1) shift from pharmacy-wholesale to direct omnichannel (own e-commerce + brand stores + marketplaces), (2) expand into Peru and Ecuador in Y2, and (3) launch the women's-health brand Mariposa as a separate identity. The CFO Sofía Carvajal-Bermúdez, the CMO Esteban Holguín-Restrepo, and the COO Camilo Restrepo-Aguirre have all individually told you "the structure is the problem" — but each has a different structure in mind. The Strategy Committee meets in 18 days.